Treatment with the cell-impermeable cyclophilin inhibitor MM284 in an animal model of autoimmune myocarditis reduced myocardial inflammation by lowering the recruitment of T cells and macrophages [19]. Here, PPIB is linked to autoimmune myocarditis.